Literature DB >> 11841825

Effect of human Apo AIV against lipid peroxidation of very low density lipoproteins.

G Ferretti1, T Bacchetti, V Bicchiega, G Curatola.   

Abstract

Recent studies have demonstrated that Apo AIV exerts a protective effect against atherosclerosis. Moreover, Qin et al. (Am. J. Physiol. 274 (1998) H1836) have demonstrated that Apo AIV, isolated from rat plasma, exerts an inhibitory effect against Cu(2+)-induced lipid peroxidation of intestinal lymph and LDL. The aim of the study was to investigate whether human Apo AIV exerts a protective effect against Cu(2+)-induced lipid peroxidation. Our results demonstrated that human Apo AIV exerted an inhibitory effect against Cu(2+) and AAPH induced lipid peroxidation of VLDL, as shown by the lower increase in the levels of TBARS and conjugated dienes in lipoproteins preincubated with Apo AIV. In addition, the tryptophan (Trp) and probe 2-(dimethylamino)-6-lauroylnaphthalene (Laurdan) fluorescence studies demonstrated that the modifications of spectral properties in both lipoproteins preincubated with Apo AIV were lower with respect to ox-lipoproteins, suggesting that Apo AIV prevents the modification of physico-chemical properties due to peroxidation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841825     DOI: 10.1016/s0009-3084(01)00201-8

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  7 in total

1.  Tgif1 represses apolipoprotein gene expression in liver.

Authors:  Tiffany A Melhuish; David D Chung; Glen A Bjerke; David Wotton
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

2.  Exploration of Serum Marker Proteins in Mice Induced by Babesia microti Infection Using a Quantitative Proteomic Approach.

Authors:  Xiaoshuang Wang; Shuguang Ren; Xiaohong Yang; Abolfazl Masoudi; Xiaomin Xue; Mengxue Li; Hongxia Li; Xiaojing Zhang; Hui Wang; Jingze Liu
Journal:  Protein J       Date:  2021-01-02       Impact factor: 2.371

3.  Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1.

Authors:  Xiaoming Li; Min Xu; Fei Wang; Alison B Kohan; Michael K Haas; Qing Yang; Danwen Lou; Silvana Obici; W Sean Davidson; Patrick Tso
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

4.  Apolipoprotein A-IV inhibits experimental colitis.

Authors:  Thorsten Vowinkel; Mikiji Mori; Christian F Krieglstein; Janice Russell; Fumito Saijo; Sulaiman Bharwani; Richard H Turnage; W Sean Davidson; Patrick Tso; D Neil Granger; Theodore J Kalogeris
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

5.  Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity.

Authors:  Jeong-Ah Yoo; Eun-Young Lee; Ji Yoon Park; Seung-Taek Lee; Sihyun Ham; Kyung-Hyun Cho
Journal:  Mol Cells       Date:  2015-05-22       Impact factor: 5.034

Review 6.  Apolipoprotein A-IV: A Multifunctional Protein Involved in Protection against Atherosclerosis and Diabetes.

Authors:  Jie Qu; Chih-Wei Ko; Patrick Tso; Aditi Bhargava
Journal:  Cells       Date:  2019-04-05       Impact factor: 6.600

Review 7.  Inhibition of Vascular Inflammation by Apolipoprotein A-IV.

Authors:  Kate Shearston; Joanne T M Tan; Blake J Cochran; Kerry-Anne Rye
Journal:  Front Cardiovasc Med       Date:  2022-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.